Operations

DAX copilot will be embedded into Epic systems and use generative AI to help providers focus more on patients and less on administrative tasks such as clinical notes.

Gee Mathen, director of pharmacy clinical applications and technical services at Texas Children's Hospital, discusses his upcoming HIMSS24 session "Combating Counterfeit Drugs and the Drug Supply Chain Security Act."

 The software company is launching its new AI-powered healthcare product that uses health organization's data to personalize patient care to reduce administrative tasks.

Prashant Natarajan, VP of strategy and products at H20.ai, says he is looking forward to discussing generative AI and the patient experience as well as strategies and success stories with fellow HIMSS24 attendees.  

The cancer support provider is partnering with insurance company Allstate to provide oncology patients with behavioral change programs.

Cleveland Clinic ACO's Dr. Jessica Hohman and Cleveland Clinic Florida's Dr. Richard Rothman discuss their upcoming HIMSS24 session on how the hospital system created and evolved its scalable home-based acute and post-acute care models.  

Health and homelessness cannot be fixed until the continuum of care around a person is solved, said Gabriel Seidman, director of policy at Ellison Institute of Technology. Tracking and responding using data is vital at government levels.  

Dr. Sashi Moodley, chief medical officer at Walgreens, discusses the reasoning behind the pharmacy store chain's recently announced closures of VillageMD clinics.

Chief information officers Cris Ross and Ed Marx discuss their book to be released in the fall, the role of technology in the patient experience, their personal health experiences and the white paper slated to be released at HIMSS24.  

Dr. Peter Bonis, chief medical officer at Wolters Kluwer Health, describes the company's AI-enabled software to detect illicit diversion of controlled and non-controlled substances in patient care and the use of AI in its wider portfolio.